DECHRA PHARMACEUTICA

DPH
Delayed Quote. Delayed  - 05/26 11:35:18 am
3552GBX +1.78%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Veterinary Drugs
Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Dechra Veterinary Products International and Dechra Pharmaceuticals Manufacturing. It manufactures and markets companion animal, equine, food producing animal products and nutrition. The North American (NA) Pharmaceuticals segment consists of Dechra Veterinary Products US, Dechra Produtas Veterinarios (Mexico) and Dechra Veterinary Products Canada, which sells companion animal, equine and food producing animal products. The segment also includes its manufacturing units based in Melbourne, Florida and Fort Worth, Texas.

Number of employees : 1 975 people.
Sales per Business
20202021
European Pharmaceuticals323.5062.8%388.5063.9%
North American Pharmaceuticals191.6037.2%219.5036.1%
GBP in Million
Sales per region
20202021
United States181.9035.3%206.5034%
Rest of Europe173.8033.7%204.8033.7%
Rest of World60.5011.7%75.0012.3%
Germany53.9010.5%64.8010.7%
United Kingdom45.008.7%56.909.4%
GBP in Million
Managers
Name Title
Ian David Page Chief Executive Officer & Executive Director
Paul Sandland Chief Financial Officer & Executive Director
Alison Elizabeth Platt Chairman
Susan Longhofer Chief Scientific Officer
Allen Mellor Group Director-Information Technology
Julian Spenser Heslop Independent Non-Executive Director
Ishbel Jean Stewart Macpherson Independent Non-Executive Director
Lawson Macartney Senior Independent Director
Anthony Gerard Griffin Executive Director & MD-Dechra Veterinary Products
Lisa Jane Bright Non-Executive Director
Shareholders
Name Equities %
Fidelity Management & Research Co. LLC 8,892,852 8.20%
The Vanguard Group, Inc. 3,973,218 3.67%
Royal London Asset Management Ltd. 3,533,800 3.26%
Grandeur Peak Global Advisors LLC 3,229,076 2.98%
Aegon Asset Management UK PLC 3,017,559 2.78%
BlackRock Investment Management (UK) Ltd. 2,875,555 2.65%
Aviva Investors Global Services Ltd. 2,640,232 2.44%
Abrdn Investment Management Ltd. 2,514,985 2.32%
Norges Bank Investment Management 2,395,000 2.21%
Aberdeen Asset Managers Ltd. 2,249,000 2.07%
Company contact information
Dechra Pharmaceuticals Plc
Cheshire Business Park
24 Cheshire Avenue
Lostock Gralam
Northwich, Cheshire CW9 7UA

Phone : +44.16.0681.4730
Fax : +44.16.0681.4731
Web : http://www.dechra.com
Sector Veterinary Drugs
1st jan.Capi. (M$)
DECHRA PHARMACEUTICALS PLC0.00%4 750
ZOETIS-33.19%76 727
ELANCO ANIMAL HEALTH INCORPORATED-17.79%11 061
DECHRA PHARMACEUTICALS PLC-34.46%4 750
BLUESTAR ADISSEO COMPANY-22.89%3 831
VIRBAC-14.96%3 256
VIMIAN GROUP AB (PUBL)-28.86%2 226
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.-8.88%1 805
VETOQUINOL SA-5.45%1 576
WUHAN KEQIAN BIOLOGY CO.,LTD-23.21%1 473
JINYU BIO-TECHNOLOGY CO., LTD.-48.01%1 414
SWEDENCARE AB (PUBL)-46.77%1 312
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.-32.55%1 141
PULIKE BIOLOGICAL ENGINEERING, INC.3.89%1 085
PHIBRO ANIMAL HEALTH CORPORATION-6.61%772
PETIQ, INC.-29.72%467
HESTER BIOSCIENCES LIMITED-14.41%239
ANIMALCARE GROUP PLC-12.32%228
ECO ANIMAL HEALTH GROUP PLC-25.63%101
Brand Portfolio
» More brands of Dechra Pharmaceuticals PLC